GLP-1 Drugs Like Ozempic Might Cut Cancer Risk Too, Study FindsObesity treatment drugs show potential anticancer effects, proving 41% more effective than surgery in preventing obesity-related cancers.
Wegovy or Wait? New Pills Could Reshape the Weight Loss Treatment LandscapeThe obesity treatment market is shifting with new oral medications emerging, offering alternatives to injectable options.
Eli Lilly Moves First in India, Beats Novo in Obesity Drug ShowdownEli Lilly launches Mounjaro in India, targeting a large market and competing with Novo Nordisk's Wegovy for obesity treatment.
Must-Reads
1
Will Korea-China summit rekindle hopes of K-culture comeback in China?
LATEST
2
Workers may soon be able to ignore late-night work messages
LATEST
3
International matchmakers under scrutiny over consumer harm
LATEST
4
Nearly 25 Islamic State fighters killed or captured in Syria, US military says
LATEST
5
Hanwha Life wins ISO certification for AI security
GLP-1 Drugs Like Ozempic Might Cut Cancer Risk Too, Study Finds Obesity treatment drugs show potential anticancer effects, proving 41% more effective than surgery in preventing obesity-related cancers.
Wegovy or Wait? New Pills Could Reshape the Weight Loss Treatment Landscape The obesity treatment market is shifting with new oral medications emerging, offering alternatives to injectable options.
Eli Lilly Moves First in India, Beats Novo in Obesity Drug Showdown Eli Lilly launches Mounjaro in India, targeting a large market and competing with Novo Nordisk's Wegovy for obesity treatment.
Hot Topics